Digoxin sensitivity in amyloid cardiomyopathy

Circulation
A RubinowA S Cohen

Abstract

Digoxin (5 mg/ml) was added to 10-mg and 20-mg pellets of purified primary and secondary amyloid fibrils, a normal human liver and heart homogenate and a homogenate from the heart of a patient with amyloid cardiomyopathy who had not received digitalis. After centrifugation, the supernatants were recovered and assayed for digoxin concentrations. Aliquots from the sediments were studied for the presence of digoxin, using rabbits antidigoxin antiserum and an indirect immunofluorescent technique. The results showed that 0.11--0.13 ng/ml of digoxin bound per milligram of fibrils and could not be separated by repeated washings. Elution with citrate or changes in the pH of the buffer. Immunofluorescent studies demonstrated diffusely bright immunofluorescence with the fibril preparation and amyloid heart homogenate when reacted with digoxin and digoxin-specific antiserum. These studies demonstrate that isolated amyloid fibrils bind digoxin and suggest that this interaction may play some role in the sensitivity to digitalis that has been observed in some patients with amyloid cardiomyopathy.

References

Jan 1, 1976·Journal of Clinical Pathology·A PomeranceJ McWatt
May 1, 1977·The American Journal of Medicine·R L RidolfiG M Hutchins
Sep 30, 1974·Clinica Chimica Acta; International Journal of Clinical Chemistry·K D BrandtA S Cohen
Sep 14, 1967·The New England Journal of Medicine·A S Cohen
Oct 1, 1970·The American Journal of Cardiology·L M BujaW C Roberts
Apr 1, 1968·The Journal of Clinical Investigation·M PrasE C Franklin
Sep 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·L BonarM M Skinner
Sep 1, 1965·British Heart Journal·A Pomerance
Jul 1, 1966·Annals of Internal Medicine·T N James
Dec 1, 1961·Annals of Internal Medicine·J T CASSIDY
Feb 1, 1965·Transactions of the New York Academy of Sciences·P SCHWARTZ

❮ Previous
Next ❯

Citations

Aug 14, 1998·Clinical Cardiology·R E McCarthy, E K Kasper
Apr 21, 2007·Journal of General Internal Medicine·Brian Garibaldi, David Zaas
Jul 9, 2011·Internal and Emergency Medicine·Federico PerfettoAlberto Moggi Pignone
Aug 25, 2006·Current Heart Failure Reports·Douglas B Sawyer, Martha Skinner
Nov 15, 2005·Current Treatment Options in Cardiovascular Medicine·Shailja Parikh, James A de Lemos
Oct 13, 2011·Current Treatment Options in Cardiovascular Medicine·Hans K Meier-EwertFrederick L Ruberg
Jul 1, 1995·Critical Reviews in Oncology/hematology·E Pascali
Apr 1, 1995·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·V M WalleyI D Young
Dec 20, 2003·Blood Reviews·Morie A GertzAngela Dispenzieri
May 1, 1985·Journal of the American College of Cardiology·E Haber
Feb 13, 1997·The New England Journal of Medicine·D R JacobsonJ N Buxbaum
Sep 26, 1997·The New England Journal of Medicine·R H FalkM Skinner
Jun 6, 2003·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Eric T StooplerSow-Yeh Chen
Jan 10, 2012·QJM : Monthly Journal of the Association of Physicians·S W Dubrey, R L Comenzo
Apr 23, 2003·Cardiology in Review·Sameer K MehtaJames A De Lemos
Dec 17, 2009·Cardiology in Review·Harit V DesaiWilliam H Frishman
Jun 1, 1990·British Heart Journal·P T Wilmshurst, D Katritsis
Oct 26, 2001·Postgraduate Medical Journal·M F Khan, R H Falk
Sep 6, 2012·Circulation·Frederick L Ruberg, John L Berk
Oct 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Takuroh ImamuraTanenao Eto
Sep 21, 2010·Clinical Medicine & Research·Satya S BhupathiRoxann Rokey
Jan 20, 2007·Southern Medical Journal·Praveen GargTimothy J Woodlock
Jan 18, 2013·Current Opinion in Cardiology·Nakul Sharma, Jonathan Howlett
Apr 27, 2002·Heart Disease·Anu Radha Kotha, Melvin B Weiss
Jan 7, 2014·Expert Review of Cardiovascular Therapy·Syed Wamique YusufMuzaffar H Qazilbash
Nov 28, 2015·Annals of Medicine·Philip N HawkinsOle B Suhr
Apr 2, 2013·Seminars in Oncology·Syed Wamique YusufDaniel J Lenihan
Mar 12, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Paul L SwiecickiMorie A Gertz
Oct 23, 2015·British Journal of Haematology·Efstathios Kastritis, Meletios A Dimopoulos
Apr 28, 2012·Blood Reviews·Angela DispenzieriFrancis Buadi
Oct 25, 2011·The American Journal of Medicine·Prashant KapoorPhilip R Greipp
Jul 14, 2011·Heart Failure Clinics·David C SeldinVaishali Sanchorawala
Nov 28, 2015·Journal of the American College of Cardiology·Morie A GertzGiampaolo Merlini
Jul 19, 2008·Progress in Cardiovascular Diseases·Steven A LubitzDavendra Mehta
Jun 8, 2004·British Journal of Haematology·UNKNOWN Guidelines Working Group of UK Myeloma Forum, UNKNOWN British Commitee for Standards in Haematology, British Society for Haematology
Mar 6, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·I M HamourN R Banner
Feb 15, 2012·Journal of the American Geriatrics Society·Kumar Dharmarajan, Mathew S Maurer
Feb 5, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M K DavisR M Witteles
Sep 1, 1984·Progress in Cardiovascular Diseases·W H Abelmann
Feb 1, 1982·Arthritis and Rheumatism·M S EganD Segal
Jun 1, 1985·The American Journal of Cardiology·M A GertzR A Kyle
Oct 11, 2014·British Journal of Haematology·Ashutosh D WechalekarUNKNOWN BCSH Committee
Jun 17, 2015·Journal of Internal Medicine·K S Patel, P N Hawkins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.